S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

$4.22
-0.23 (-5.17%)
(As of 03/28/2024 ET)
Today's Range
$4.22
$4.64
50-Day Range
$2.41
$6.77
52-Week Range
$2.28
$49.20
Volume
44,802 shs
Average Volume
3.35 million shs
Market Capitalization
$11.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Intelligent Bio Solutions MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
3.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.31mentions of Intelligent Bio Solutions in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.67) to ($1.25) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.29 out of 5 stars

Medical Sector

913th out of 938 stocks

Surgical & Medical Instruments Industry

93rd out of 94 stocks

INBS stock logo

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

INBS Stock Price History

INBS Stock News Headlines

Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Intelligent Bio Solutions Announces $10.1 Mln Private Placement
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
See More Headlines
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2024
Today
3/28/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:INBS
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

Net Income
$-10,630,000.00
Net Margins
-544.63%
Pretax Margin
-546.02%

Debt

Sales & Book Value

Annual Sales
$1.26 million
Book Value
$18.99 per share

Miscellaneous

Free Float
2,836,000
Market Cap
$12.21 million
Optionable
Not Optionable
Beta
4.88
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Harry Simeonidis (Age 57)
    President & CEO
    Comp: $310.79k
  • Mr. Spiro Kevin Sakiris B.Bus (Age 62)
    C.A., CA, Dip Law, Chief Financial Officer
    Comp: $274.43k
  • Ms. Victoria Gavrilenko (Age 41)
    Operations Manager
    Comp: $45k
  • Mr. Alex Arzeno
    VP of Investor Relations

INBS Stock Analysis - Frequently Asked Questions

How have INBS shares performed in 2024?

Intelligent Bio Solutions' stock was trading at $4.0548 at the beginning of the year. Since then, INBS stock has increased by 4.1% and is now trading at $4.22.
View the best growth stocks for 2024 here
.

Are investors shorting Intelligent Bio Solutions?

Intelligent Bio Solutions saw a increase in short interest in March. As of March 15th, there was short interest totaling 91,000 shares, an increase of 107.3% from the February 29th total of 43,900 shares. Based on an average trading volume of 3,150,000 shares, the short-interest ratio is presently 0.0 days. Approximately 3.2% of the shares of the company are short sold.
View Intelligent Bio Solutions' Short Interest
.

When is Intelligent Bio Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our INBS earnings forecast
.

How were Intelligent Bio Solutions' earnings last quarter?

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced its quarterly earnings results on Friday, February, 9th. The company reported ($2.07) earnings per share for the quarter, beating the consensus estimate of ($3.24) by $1.17. The firm had revenue of $0.76 million for the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 266.16% and a negative net margin of 544.63%.

When did Intelligent Bio Solutions' stock split?

Intelligent Bio Solutions's stock reverse split on Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What guidance has Intelligent Bio Solutions issued on next quarter's earnings?

Intelligent Bio Solutions updated its second quarter 2024 earnings guidance on Friday, February, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.6 million-$1.6 million, compared to the consensus revenue estimate of $1.0 million.

Who are Intelligent Bio Solutions' major shareholders?

Intelligent Bio Solutions' stock is owned by a number of institutional and retail investors. Top institutional investors include Citadel Advisors LLC (21.48%).
View institutional ownership trends
.

How do I buy shares of Intelligent Bio Solutions?

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INBS) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners